{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1360021391885749120.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1111/tan.15472"}},{"identifier":{"@type":"URI","@value":"https://onlinelibrary.wiley.com/doi/pdf/10.1111/tan.15472"}}],"resourceType":"学術雑誌論文(journal article)","dc:title":[{"@value":"Assessment of cancer cell‐expressed <scp>HLA class I</scp> molecules and their immunopathological implications"}],"description":[{"type":"abstract","notation":[{"@value":"<jats:p>Immunotherapy using immune checkpoint inhibitors (ICIs) has shown superior efficacy compared with conventional chemotherapy in certain cancer types, establishing immunotherapy as the fourth standard treatment alongside surgical intervention, chemotherapy, and radiotherapy. In cancer immunotherapy employing ICIs, CD8‐positive cytotoxic T lymphocytes are recognized as the primary effector cells. For effective clinical outcomes, it is essential that the targeted cancer cells express HLA class I molecules to present antigenic peptides derived from the tumor. However, cancer cells utilize various mechanisms to downregulate or lose HLA class I molecules from their surface, resulting in evasion from immune surveillance. Correlations between prognosis and the integrity of HLA class I molecules expressed by cancer cells have been consistently found across different types of cancer. This paper provides an overview of the regulatory mechanisms of HLA class I molecules and their role in cancer immunotherapy, with a particular emphasis on the significance of utilizing pathological tissues to evaluate HLA class I molecules expressed in cancer cells.</jats:p>"}]}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1380021391885749250","@type":"Researcher","foaf:name":[{"@value":"Terufumi Kubo"}],"jpcoar:affiliationName":[{"@value":"Department of Pathology School of Medicine, Sapporo Medical University  Sapporo Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021391885749122","@type":"Researcher","foaf:name":[{"@value":"Shiori Asano"}],"jpcoar:affiliationName":[{"@value":"Department of Pathology School of Medicine, Sapporo Medical University  Sapporo Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021391885748996","@type":"Researcher","foaf:name":[{"@value":"Kenta Sasaki"}],"jpcoar:affiliationName":[{"@value":"Department of Pathology School of Medicine, Sapporo Medical University  Sapporo Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021391885749124","@type":"Researcher","foaf:name":[{"@value":"Kenji Murata"}],"jpcoar:affiliationName":[{"@value":"Department of Pathology School of Medicine, Sapporo Medical University  Sapporo Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021391885749127","@type":"Researcher","foaf:name":[{"@value":"Takayuki Kanaseki"}],"jpcoar:affiliationName":[{"@value":"Department of Pathology School of Medicine, Sapporo Medical University  Sapporo Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021391885748994","@type":"Researcher","foaf:name":[{"@value":"Tomohide Tsukahara"}],"jpcoar:affiliationName":[{"@value":"Department of Pathology School of Medicine, Sapporo Medical University  Sapporo Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021391885749121","@type":"Researcher","foaf:name":[{"@value":"Yoshihiko Hirohashi"}],"jpcoar:affiliationName":[{"@value":"Department of Pathology School of Medicine, Sapporo Medical University  Sapporo Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021391885749249","@type":"Researcher","foaf:name":[{"@value":"Toshihiko Torigoe"}],"jpcoar:affiliationName":[{"@value":"Department of Pathology School of Medicine, Sapporo Medical University  Sapporo Japan"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"20592302"},{"@type":"EISSN","@value":"20592310"}],"prism:publicationName":[{"@value":"HLA"}],"dc:publisher":[{"@value":"Wiley"}],"prism:publicationDate":"2024-05","prism:volume":"103","prism:number":"5"},"reviewed":"false","dc:rights":["http://creativecommons.org/licenses/by-nc-nd/4.0/"],"url":[{"@id":"https://onlinelibrary.wiley.com/doi/pdf/10.1111/tan.15472"}],"createdAt":"2024-05-03","modifiedAt":"2025-01-07","project":[{"@id":"https://cir.nii.ac.jp/crid/1040299826881066880","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"23K27387"},{"@type":"JGN","@value":"JP23K27387"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-23K27387/"}],"notation":[{"@language":"ja","@value":"病理組織学的解析と免疫学的解析の融合による次世代腫瘍微小環境解析"},{"@language":"en","@value":"Next-generation tumor microenvironment analysis through integration of pathological and immunological analyses"}]}],"relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1050001202611941248","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Clinical implication of HLA class I expression in breast cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1360002218146080384","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Immune responses to human cancer stem‐like cells/cancer‐initiating cells"}]},{"@id":"https://cir.nii.ac.jp/crid/1360011143845526912","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The Predictive Value of HLA Class I Tumor Cell Expression and Presence of Intratumoral Tregs for Chemotherapy in Patients with Early Breast Cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1360011146126858752","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Down-Regulation of HLA Class I Antigens in Prostate Cancer Tissues and Up-Regulation by Histone Deacetylase Inhibition"}]},{"@id":"https://cir.nii.ac.jp/crid/1360011146306539904","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Frequent loss of heterozygosity in the β2-microglobulin region of chromosome 15 in primary human tumors"}]},{"@id":"https://cir.nii.ac.jp/crid/1360013171201412608","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Evolutionary divergence of HLA class I genotype impacts efficacy of cancer immunotherapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360013171598526848","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Differences in the immunosurveillance pattern associated with DNA mismatch repair status between right‐sided and left‐sided colorectal cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1360013171702534272","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The comparison between adenocarcinoma and squamous cell carcinoma in lung cancer patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1360021392662381056","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Differential HLA class I subunit (A, B, C heavy chain and β2-microglobulin) expression levels in normal tissues"}]},{"@id":"https://cir.nii.ac.jp/crid/1360021392662710144","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"A membrane-associated MHC-I inhibitory axis for cancer immune evasion"}]},{"@id":"https://cir.nii.ac.jp/crid/1360021392662712832","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Loss of HLA-class-I expression in non-small-cell lung cancer: Association with prognosis and anaerobic metabolism"}]},{"@id":"https://cir.nii.ac.jp/crid/1360021392663401984","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The functional diversity of tissue‐resident natural killer cells against infection"}]},{"@id":"https://cir.nii.ac.jp/crid/1360021392663460224","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Differential role of HLA-A and HLA-B, C expression levels as prognostic markers in colon and rectal cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1360021392663792768","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Tumor Microenvironment, HLA Class I and APM Expression in HPV-Negative Oral Squamous Cell Carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360021392663932800","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"NLRC5 Deficiency Selectively Impairs MHC Class I- Dependent Lymphocyte Killing by Cytotoxic T Cells"}]},{"@id":"https://cir.nii.ac.jp/crid/1360021392663937024","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Characterization of the Interactions Between MHC Class I Subunits: A Systematic Approach for the Engineering of Higher Affinity Variants of β2-Microglobulin"}]},{"@id":"https://cir.nii.ac.jp/crid/1360021392663942912","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Loss of Human Leukocyte Antigen Class I Expression Is Associated with Poor Prognosis in Patients with Advanced Breast Cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1360021392663943936","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Human Leukocyte Antigen Class I and Programmed Death-Ligand 1 Coexpression Is an Independent Poor Prognostic Factor in Adenocarcinoma of the Lung"}]},{"@id":"https://cir.nii.ac.jp/crid/1360021393299351040","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"MHC class I loss in endometrial carcinoma: a potential resistance mechanism to immune checkpoint inhibition"}]},{"@id":"https://cir.nii.ac.jp/crid/1360021393779937024","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"γδ T cells are effectors of immunotherapy in cancers with HLA class I defects"}]},{"@id":"https://cir.nii.ac.jp/crid/1360021396354384128","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Prognostic and Clinical Significance of Human Leukocyte Antigen Class I Expression in Breast Cancer: A Meta-Analysis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360021396354735744","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Epigenetic priming restores the HLA class-I antigen processing machinery expression in Merkel cell carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360021396354747008","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Reversible epigenetic alterations regulate class I HLA loss in prostate cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1360021396354750976","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"CD8+ T cells maintain killing of MHC-I-negative tumor cells through the NKG2D–NKG2DL axis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360021396355131648","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Expression of human leukocyte antigen class I and β2‐microglobulin in colorectal cancer and its prognostic impact"}]},{"@id":"https://cir.nii.ac.jp/crid/1360021396355367424","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Prognostic significance of HLA EMR8-5 immunohistochemically analyzed expression in osteosarcoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360021396355457152","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Relationship between Kita-Kyushu Lung Cancer antigen-1 expression and prognosis of cases with lung squamous cell carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360021396534538624","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Natural killer cells infiltrating colorectal cancer and MHC class I expression"}]},{"@id":"https://cir.nii.ac.jp/crid/1360021396534732288","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Expression of HLA class I is associated with immune cell infiltration and patient outcome in breast cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1360021396534952576","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"HLA-A, -B, -C Expression in Colon Carcinoma Mimics That of the Normal Colonic Mucosa and is Prognostically Relevant"}]},{"@id":"https://cir.nii.ac.jp/crid/1360021396535201920","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Loss of human leucocyte antigen class I and gain of class II expression are early events in carcinogenesis: clues from a study of Barrett’s oesophagus"}]},{"@id":"https://cir.nii.ac.jp/crid/1360021396535203200","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Gene signature of antigen processing and presentation machinery predicts response to checkpoint blockade in non-small cell lung cancer (NSCLC) and melanoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360021396535237248","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The Challenges of HLA Class I Loss in Cancer Immunotherapy: Facts and Hopes"}]},{"@id":"https://cir.nii.ac.jp/crid/1360021396535240960","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Hallmarks of Resistance to Immune-Checkpoint Inhibitors"}]},{"@id":"https://cir.nii.ac.jp/crid/1360021396535312000","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Human leucocyte antigen class I in hormone receptor-positive, HER2-negative breast cancer: association with response and survival after neoadjuvant chemotherapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360021396535697920","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"A method for semi-automated image analysis of HLA class I tumour epithelium expression in rectal cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1360282589101505024","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Incidence, risk factors and clinical outcome of leukemia relapses with loss of the mismatched HLA after partially incompatible hematopoietic stem cell transplantation"}]},{"@id":"https://cir.nii.ac.jp/crid/1360283693198785792","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Establishment of a monoclonal anti‐pan HLA class I antibody suitable for immunostaining of formalin‐fixed tissue: Unusually high frequency of down‐regulation in breast cancer tissues"}]},{"@id":"https://cir.nii.ac.jp/crid/1360283693667230336","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Prognostic Impact of Human Leukocyte Antigen Class I Expression and Association of Platinum Resistance with Immunologic Profiles in Epithelial Ovarian Cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285706171221248","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Prognostic significance of HLA class I and II expression in patients with diffuse large B cell lymphoma treated with standard chemoimmunotherapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285710528420736","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Human leukocyte antigen class I down‐regulation in muscle‐invasive bladder cancer: Its association with clinical characteristics and survival after cystectomy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285711962207232","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Expression of PD-L1 and HLA Class I in Esophageal Squamous Cell Carcinoma: Prognostic Factors for Patient Outcome"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285712531747584","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"HLA Class I Expression and Its Alteration by Preoperative Hyperthermo-Chemoradiotherapy in Patients with Rectal Cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1360290617624688768","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Human leukocyte antigen I is significantly downregulated in patients with myxoid liposarcomas"}]},{"@id":"https://cir.nii.ac.jp/crid/1360292618562515328","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The monoclonal antibody HCA2 recognises a broadly shared epitope on selected classical as well as several non-classical hla class i molecules"}]},{"@id":"https://cir.nii.ac.jp/crid/1360292619735694592","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360292620449966208","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Down-Regulation of HLA Class I Antigen-Processing Molecules in Malignant Melanoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360294643825320192","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Human Leukocyte Antigen Class I Deficiency in Gastric Carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360294645395324928","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation"}]},{"@id":"https://cir.nii.ac.jp/crid/1360294647260474368","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Tumor mutational load, CD8+ T cells, expression of PD-L1 and HLA class I to guide immunotherapy decisions in NSCLC patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1360294647741105920","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"HLA class I loss in colorectal cancer: implications for immune escape and immunotherapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360294647850004096","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Somatic HLA Class I Loss Is a Widespread Mechanism of Immune Evasion Which Refines the Use of Tumor Mutational Burden as a Biomarker of Checkpoint Inhibitor Response"}]},{"@id":"https://cir.nii.ac.jp/crid/1360294663001346048","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"HLA Class I Antigen Down-Regulation in Primary Ovary Carcinoma Lesions: Association with Disease Stage"}]},{"@id":"https://cir.nii.ac.jp/crid/1360294663398278656","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Why certain antibodies cross-react with HLA- A and HLA-G: Epitope mapping of two common MHC class I reagentsfn2fn2This work was supported by a grant from the National Institutes of Health (R01AI38577-01) and by a Reproductive Scientist Development Award, the Society for Gynecologic Investigation, and National Institutes of Health Grant K12HD00849 (to D.J.S.)"}]},{"@id":"https://cir.nii.ac.jp/crid/1360300160005059968","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"A guide to antigen processing and presentation"}]},{"@id":"https://cir.nii.ac.jp/crid/1360302864803544960","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Eribulin is an immune potentiator in breast cancer that upregulates human leukocyte antigen class I expression via the induction of NOD‐like receptor family CARD domain‐containing 5"}]},{"@id":"https://cir.nii.ac.jp/crid/1360302871986567808","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"HLA Class I Downregulation in Progressing Metastases of Melanoma Patients Treated With Ipilimumab"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565165279979392","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Prognostic impact of programmed cell death 1 ligand 1 expression in human leukocyte antigen class I-positive hepatocellular carcinoma after curative hepatectomy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567185443779072","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Prognostic impact of the tumor immune microenvironment in synovial sarcoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567186784583296","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Prognostic value of HLA class I expression in patients with colorectal cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1360572092720272768","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Less correlation between mismatch repair proteins deficiency and decreased expression of HLA class I molecules in endometrial carcinoma: a different propensity from colorectal cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574094164700544","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Pathways of Antigen Processing"}]},{"@id":"https://cir.nii.ac.jp/crid/1360579820511987456","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Abandoning the Notion of Non-Small Cell Lung Cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1360580237142294400","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"In vivo detection of antigen-specific CD8+ T cells by immuno-positron emission tomography"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584343267629184","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Strong CD8+ lymphocyte infiltration in combination with expression of HLA class I is associated with better tumor control in breast cancer patients treated with neoadjuvant chemotherapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584343267922944","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Down-regulation of human leukocyte antigen class I (HLA-I) is associated with poor prognosis in patients with clear cell renal cell carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584343267984128","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Association of HLA diversity with the risk of 25 cancers in the UK Biobank"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584343268092288","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Reliability and Variability of Ki-67 Digital Image Analysis Methods for Clinical Diagnostics in Breast Cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584343268122368","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Tumor cell HLA class I expression and pathologic response following neoadjuvant immunotherapy for newly diagnosed head and neck cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584343268657152","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Intracellular Assembly and Trafficking of MHC Class I Molecules"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584343268717568","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Distribution of HLA class 1 antigens in normal human tissue and in mammary cancer."}]},{"@id":"https://cir.nii.ac.jp/crid/1360584343269169664","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Prognostic Value of HLA Class I in Patients with Hepatocellular Carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584343504410240","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Role of the anatomic site in the association of HLA class I antigen expression level in metastases with clinical response to ipilimumab therapy in patients with melanoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584346970760192","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Downregulation of human leukocyte antigen Class I expression: An independent prognostic factor in colorectal cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848655131832704","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Prognostic significance of HLA class I expression in Ewing's sarcoma family of tumors"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848657256929536","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Prognostic implications of human leukocyte antigen class I expression in patients who underwent surgical resection for non–small-cell lung cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848663497711104","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Mismatch Repair Protein Deficiency Is a Risk Factor for Aberrant Expression of HLA Class I Molecules: A Putative \"Adaptive Immune Escape\" Phenomenon"}]},{"@id":"https://cir.nii.ac.jp/crid/1360849945420811392","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Higher human lymphocyte antigen class I expression in early‐stage cancer cells leads to high sensitivity for cytotoxic T lymphocytes"}]},{"@id":"https://cir.nii.ac.jp/crid/1360855570124610176","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Genomic correlates of response to CTLA-4 blockade in metastatic melanoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360857597686008192","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"HLA-corrected tumor mutation burden and homologous recombination deficiency for the prediction of response to PD-(L)1 blockade in advanced non-small-cell lung cancer patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1360861294962526592","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Assessment of Patient-Specific Human Leukocyte Antigen Genomic Loss at Relapse After Antithymocyte Globulin–Based T-Cell–Replete Haploidentical Hematopoietic Stem Cell Transplant"}]},{"@id":"https://cir.nii.ac.jp/crid/1360861707396716288","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Fundamental and Essential Knowledge for Pathologists Engaged in the Research and Practice of Immune Checkpoint Inhibitor-Based Cancer Immunotherapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360861710477231744","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The PET-Tracer 89Zr-Df-IAB22M2C Enables Monitoring of Intratumoral CD8 T-cell Infiltrates in Tumor-Bearing Humanized Mice after T-cell Bispecific Antibody Treatment"}]},{"@id":"https://cir.nii.ac.jp/crid/1360861711918461824","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Cancer evolution: Darwin and beyond"}]},{"@id":"https://cir.nii.ac.jp/crid/1360861712155766400","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"DUX4 Suppresses MHC Class I to Promote Cancer Immune Evasion and Resistance to Checkpoint Blockade"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137043502158080","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Natural killer cell education in human health and disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137043811787520","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137045015486976","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Polymorphism in the α3 domain of HLA-A molecules affects binding to CD8"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137045200789248","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Loss of Mismatched HLA in Leukemia after Stem-Cell Transplantation"}]},{"@id":"https://cir.nii.ac.jp/crid/1361412895374631424","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Prognostic value of HLA class I expression in patients with oral squamous cell carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1361412895374679936","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Expression of classical human leukocyte antigen class I antigens, HLA‐E and HLA‐G, is adversely prognostic in pancreatic cancer patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418518709906560","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Association of immunoescape mechanisms with Epstein‐Barr virus infection in nasopharyngeal carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418518847576064","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Down-Regulation of HLA Class I Antigen is an Independent Prognostic Factor for Clear Cell Renal Cell Carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418518938038784","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"An IFN-γ–induced aminopeptidase in the ER, ERAP1, trims precursors to MHC class I–presented peptides"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418519683050880","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Validation of the systematic scoring of immunohistochemically stained tumour tissue microarrays using <i>QuPath</i> digital image analysis"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418520014784512","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Total loss of MHC class I is an independent indicator of good prognosis in breast cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418520580223488","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"HLA Class I Antigen Processing Machinery Component Expression and Intratumoral T-Cell Infiltrate as Independent Prognostic Markers in Ovarian Carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981470093750016","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981470507389056","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Downregulation of HLA Class I molecules in the tumour is associated with a poor prognosis in patients with oesophageal squamous cell carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981470880861952","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Association of CD8+ T cell infiltration in oesophageal carcinoma lesions with human leucocyte antigen (HLA) class I antigen expression and survival"}]},{"@id":"https://cir.nii.ac.jp/crid/1362262943326248448","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"HLA Class I Antigen Down-regulation in Primary Laryngeal Squamous Cell Carcinoma Lesions as a Poor Prognostic Marker"}]},{"@id":"https://cir.nii.ac.jp/crid/1362262944981296896","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Mice Lacking the MHC Class II Transactivator (CIITA) Show Tissue-Specific Impairment of MHC Class II Expression"}]},{"@id":"https://cir.nii.ac.jp/crid/1362262945312966528","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"HLA class I antigen and transporter associated with antigen processing downregulation in metastatic lesions of head and neck squamous cell carcinoma as a marker of poor prognosis"}]},{"@id":"https://cir.nii.ac.jp/crid/1362262945796553600","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"HLA‐class I expression in gastric cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1362262945997123456","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1362262946167699072","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Is downregulation of MHC class I antigen expression in human non-small cell lung cancer associated with prolonged survival?"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544418791494784","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The bodies fight against cancer: is human leucocyte antigen (HLA) class 1 the key?"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544420430459264","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Prognostic significance of HLA class I expression in osteosarcoma defined by anti‐pan HLA class I monoclonal antibody, EMR8‐5"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825894172656512","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Human Leukocyte Antigen Class I Antigen Expression Is an Independent Prognostic Factor in Ovarian Cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825894704643072","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Clinical significance of HLA class I heavy chain expression in patients with gastric cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825894926266624","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Prognostic Significance of HLA Class I Expressing in Gastric Carcinoma Defined by Monoclonal Anti-Pan HLA Class I Antibody, EMR8-5"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107368324303744","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"HLA-A- and HLA-B-specific monoclonal antibodies reactive with free heavy chains in Western blots, in formalin-fixed, paraffin-embedded tissue sections and in cryo-immuno-electron microscopy"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107368543000832","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Down-Regulation of HLA-A Expression Correlates with a Better Prognosis in Colorectal Cancer Patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107368698134912","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"NLR family member NLRC5 is a transcriptional regulator of MHC class I genes"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107370096340224","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The role of classical and non-classical HLA class I antigens in human tumors"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107370144924672","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Cross-presentation by dendritic cells"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107370884315904","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Clinical impact of HLA class I expression in rectal cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388843725698176","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Down-regulation of Human Leukocyte Antigen class I heavy chain in tumors is associated with a poor prognosis in advanced esophageal cancer patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388844660433920","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Up-regulation of HLA class-I antigen expression and antigen-specific CTL response in cervical cancer cells by the demethylating agent hydralazine and the histone deacetylase inhibitor valproic acid"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388845796023552","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"MHC Class I Loss Is a Frequent Mechanism of Immune Escape in Papillary Thyroid Cancer That Is Reversed by Interferon and Selumetinib Treatment\n                    <i>In Vitro</i>"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670319194824832","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670319772757248","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung Cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1363951793187593728","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Immunosurveillance is active in colorectal cancer as downregulation but not complete loss of MHC class I expression correlates with a poor prognosis"}]},{"@id":"https://cir.nii.ac.jp/crid/1363951793475677568","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"NLRC5/MHC class I transactivator is a target for immune evasion in cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1363951793712559872","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The HLA System"}]},{"@id":"https://cir.nii.ac.jp/crid/1363951793817091840","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Resistance to checkpoint blockade therapy through inactivation of antigen presentation"}]},{"@id":"https://cir.nii.ac.jp/crid/1363951793960861952","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Down-regulation of HLA class I antigen-processing machinery components in esophageal squamous cell carcinomas: Association with disease progression"}]},{"@id":"https://cir.nii.ac.jp/crid/1363951794848910720","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Down-regulation of the antigen processing machinery is linked to a loss of inflammatory response in colorectal cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1363951795751546624","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"MHC proteins confer differential sensitivity to CTLA-4 and PD-1 blockade in untreated metastatic melanoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233271238425088","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Expression of HLA Class I Antigen, Aspirin Use, and Survival After a Diagnosis of Colon Cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1370021391885748998","@type":"Product","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The escape of cancer from T cell‐mediated immune surveillance: HLA class I loss and tumor tissue architecture"}]},{"@id":"https://cir.nii.ac.jp/crid/1370021391885749027","@type":"Product","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Role of non‐classical MHC class I molecules in cancer immunosuppression"}]},{"@id":"https://cir.nii.ac.jp/crid/1370021391885749125","@type":"Product","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"What's new in the WHO 2022 classification of kidney tumours?"}]},{"@id":"https://cir.nii.ac.jp/crid/1370021391885749130","@type":"Product","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Association of tapasin and HLA class I antigen down‐regulation in primary maxillary sinus squamous cell carcinoma lesions with reduced survival of patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1370021391885749139","@type":"Product","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Clinical significance of expression of cancer/testis antigen and down‐regulation of HLA class‐I in patients with stage I non‐small cell lung cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1370021391885749142","@type":"Product","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Downregulated expression of human leukocyte antigen class I heavy chain is associated with poor prognosis in non‐small‐cell lung cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1370021391885749248","@type":"Product","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"HLA and proteasome expression body map"}]},{"@id":"https://cir.nii.ac.jp/crid/1370021391885749283","@type":"Product","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"HLA‐A24 ligandome analysis of colon and lung cancer cells identifies a novel cancer‐testis antigen and a neoantigen that elicits specific and strong CTL responses"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1111/tan.15472"},{"@type":"KAKEN","@value":"PRODUCT-25302639"},{"@type":"KAKEN","@value":"PRODUCT-25631831"},{"@type":"OPENAIRE","@value":"doi_________::7bd923d6d0912cddb086d3161ad6b96a"}]}